S&P 500 Futures
(0.12%) 5 333.50 points

Dow Jones Futures
(0.03%) 40 148 points

Nasdaq Futures
(0.15%) 18 664 points

Oil
(-0.37%) $79.76

Gas
(0.57%) $2.64

Gold
(1.35%) $2 450.00

Silver
(3.11%) $32.23

Platinum
(0.37%) $1 094.00

USD/EUR
(0.04%) $0.920

USD/NOK
(0.01%) $10.68

USD/GBP
(0.03%) $0.787

USD/RUB
(-0.42%) $90.59

Realtime updates for ADiTx Therapeutics, Inc. [ADTX]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Upcoming Earnings Alert

Quarter results today
(bmo 2024-05-20)

Expected move: +/- 22.82%

Last Updated17 May 2024 @ 16:00

25% discount on Stockinvest.us - Use code: Podcast

-0.99% $ 2.01

SELL 139091 min ago

@ $4.00

Issued: 13 Feb 2024 @ 14:29

Return: -49.75%

Live Chart Being Loaded With Signals

Commentary (17 May 2024 @ 16:00):

Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. It develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its own tissues...

Stats
Today's Volume	18 165.00
Average Volume	355 415
Market Cap	3.94M
EPS	$0 ( 2024-04-02 )
Next earnings date	( $0 ) 2024-08-15
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0200
ATR14	$0.0200 (1.00%)

Insider Trading

Date	Person	Action	Amount	type
2023-11-08	Runge Jeffrey W.	Buy	470	Options (right to buy)
2023-11-08	Albanna Rowena	Buy	4 702	Options (right to buy)
2023-11-08	Nelson Charles Athle	Buy	470	Options (right to buy)
2023-11-08	Albanna Amro A.	Buy	9 404	Options (right to buy)
2023-11-08	Pankovcin Corinne	Buy	4 702	Options (right to buy)

INSIDER POWER
26.74
Last 84 transactions
Buy: 1 934 500 \| Sell: 1 185 103

ADiTx Therapeutics, Inc. Correlation

10 Most Positive Correlations
WBA	0.942
MVST	0.94
PACB	0.937
NEOG	0.936
BYFC	0.935
FTHM	0.934
VVOS	0.932
NFE	0.931
CFFI	0.929
DCFC	0.927

10 Most Negative Correlations
APXI	-0.922
IGTA	-0.919
SWAV	-0.91
REAX	-0.91
HYAC	-0.909
BSCO	-0.907
BCSA	-0.906
AEAE	-0.901
ACGL	-0.898
BOCN	-0.897

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

ADiTx Therapeutics, Inc. Correlation - Currency/Commodity

0.49
( neutral )

0.48
( neutral )

0.00
( neutral )

0.47
( neutral )

0.22
( neutral )

0.33
( neutral )

ADiTx Therapeutics, Inc. Financials

Annual	2023
Revenue:	$645 176
Gross Profit:	$-654 243 (-101.41 %)
EPS:	$-107.10

FY	2023
Revenue:	$645 176
Gross Profit:	$-654 243 (-101.41 %)
EPS:	$-107.10

FY	2022
Revenue:	$933 715
Gross Profit:	$166 936 (17.88 %)
EPS:	$-608.04

FY	2021
Revenue:	$105 034
Gross Profit:	$27 055.00 (25.76 %)
EPS:	$-6.72

Financial Reports:

No articles found.

ADiTx Therapeutics, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

ADiTx Therapeutics, Inc.

Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. It develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its own tissues. The company is also developing ADi products for organ transplantation, including skin grafting, autoimmune diseases, and allergies. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Richmond, Virginia.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Investing in the stock market involves risk and the value of your investment can fluctuate. The stock market can be affected by a variety of factors, including economic conditions, company performance, and global events. There is no guarantee of profit and you could lose money. Please consider your financial situation, investment goals, and level of risk tolerance before making any investment decisions. Consult with a financial advisor for personalized advice.